RJR 2403

Drug Profile

RJR 2403

Alternative Names: Metanicotine

Latest Information Update: 05 Nov 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator R. J. Reynolds Tobacco Company
  • Class Neuroprotectants; Nootropics; Pyridines; Small molecules; Solanaceous alkaloids
  • Mechanism of Action Nicotinic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cognition disorders

Most Recent Events

  • 09 May 2001 Discontinued - Preclinical for Cognition disorders in USA (unspecified route)
  • 09 May 2000 No-Development-Reported for Cognition disorders in USA (Unknown route)
  • 19 Feb 1997 A study has been added to the pharmacodynamics and adverse effects sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top